Methylcobalamin Deficiency Type Cbl G (Disorder)

Oncology·MeSH: Mucopolysaccharidosis III

Prevalence

0.1 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Methylcobalamin Deficiency Type Cbl G (Disorder)?

There are 1 clinical trial targeting Methylcobalamin Deficiency Type Cbl G (Disorder) tracked by BioSniper.

What is the prevalence of Methylcobalamin Deficiency Type Cbl G (Disorder)?

The estimated prevalence of Methylcobalamin Deficiency Type Cbl G (Disorder) is approximately 0.1 per 100,000 population.

Deep-dive into Methylcobalamin Deficiency Type Cbl G (Disorder)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Methylcobalamin Deficiency Type Cbl G (Disorder) — Drugs in Development & Clinical Trials | BioSniper